Trends in Prices of Popular Brand-Name Prescription Drugs in the United States | Zendy

Nathan E. Wineinger | Zendy; Yunyue Zhang | Zendy; Eric J. Topol | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Trends in Prices of Popular Brand-Name Prescription Drugs in the United States

Author(s) -

Nathan E. Wineinger,

Yunyue Zhang,

Eric J. Topol

Publication year - 2019

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2019.4791

Subject(s) - medical prescription , brand names , pharmacy , prescription drug , medicine , generic drug , drug prices , business , family medicine , drug , advertising , pharmacology , public economics , economics

Key Points Question What are the prices of top-selling brand-name prescription drugs in the United States, and how have these prices changed in recent years? Findings In this economic evaluation of 49 common top-selling brand-name drugs, 78% of the drugs that have been available since 2012 have seen an increase in insurer and out-of-pocket costs by more than 50%, and 44% have more than doubled in price. Meaning Prices of brand-name drugs in the United States are likely to continue to increase, which warrants greater price transparency.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research